In this study, we identified that CSN6 was overexpressed in human melanoma tissue samples and cells, high expression of CSN6 was a poor prognostic factor for melanoma patients and increased expression of CSN6 was positively correlated with tumor stage, indicating that CSN6 might be a biomarker in melanoma. This evidence concerns the gene COPS6 and neoplasm.